Calithera Biosciences, Inc. (CALA)
- Previous Close
0.0200 - Open
0.0200 - Bid --
- Ask --
- Day's Range
0.0200 - 0.0200 - 52 Week Range
0.0150 - 0.4999 - Volume
9,990 - Avg. Volume
955 - Market Cap (intraday)
97,450 - Beta (5Y Monthly) -0.06
- PE Ratio (TTM)
-- - EPS (TTM)
-7.9400 - Earnings Date Mar 29, 2024 - Apr 2, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.
www.calithera.comRecent News: CALA
Performance Overview: CALA
Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CALA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CALA
Valuation Measures
Market Cap
97.45k
Enterprise Value
-1.35M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-56.29%
Return on Equity (ttm)
-114.14%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-21.29M
Diluted EPS (ttm)
-7.9400
Balance Sheet and Cash Flow
Total Cash (mrq)
25.45M
Total Debt/Equity (mrq)
8.17%
Levered Free Cash Flow (ttm)
-28.17M
Research Analysis: CALA
Company Insights: CALA
CALA does not have Company Insights